Adenocarcinoma, Clear Cell - 82 Studies Found
Recruiting |
: Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer :
|
Recruiting |
: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer :
|
Completed |
: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer :
|
Completed |
: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer :
|
Active, not recruiting |
: Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer :
|
Recruiting |
: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer :
|
Not yet recruiting |
: VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer :
|
Recruiting |
: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas :
: 2012-06-19 : |
Recruiting |
: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer :
|
Recruiting |
: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer :
|